BSEGeneral7 Oct 2026 · 7 Oct 2026, 06:44 pm

NON- APPLICABILITY CERTIFICATE UNDER REGULATION 57(5) FOR THE QUARTER ENDED 30.09.2026

Beryl Drugs Ltd · 524606

✦ AI Summarycompliance

Beryl Drugs Ltd has filed a non-applicability certificate under Regulation 57(5) for the quarter ended 30.09.2026, stating that there are no non-convertible securities for which interest/dividend/principal is payable during the quarter.

Analysis Scores

Earnings Impact5/10
Growth Catalyst1/10
Governance Concern1/10
Regulatory Risk2/10
Balance Sheet Risk1/10
Liquidity Impact8/10
Market Sentiment5/10

✦ Ask a Question

Ask anything about this announcement — AI will answer based on the filing content.

0/500

Full Announcement

Beryl Drugs Ltd - 524606 - Compliance-57 (5) : intimation after the end of quarter

Attachments (1)

📄

874faff7-5431-4c73-9c1a-0a22b1c7b299.pdf

pdf

Download →
View document text
BERYL. orves tures TR ee lg .d :. (O 0f 7f 3. 1: )2 9 2, 1N 7e 6e 7r g Ear -, a" iM la y a bn ek yW la dt re ur sP 2a 5rk yR ao ha od o" ., oBi mc h |o l Ci H Na p :s i L, 2I 4N 2D 3O MR PE 1- 94 95 32 P0 L1 C6 ( 7M 8.P 4. 0) INDIA Date: 06" October, 2026 The DCS- Listing, The Bombay Stock Exchange Limited, Phiroze JeeJeebhoy Towers, Dalal Street, Mumbai — 400 001 Script Code: 524606 Sub.: Filing of Reports for the quarter ended on 30.09.2026 Dear Sir, With reference to various conditions stipulated under the SEBI (Listing Obligations and Disclosure Requirements) Regulations, 2015 and other regulation required to be complied by the listed Companies, we are enclosing herewith the following documents for your record, relating to quarter ended on 30th September, 2026 1. Regulation 74 (5) - Certificate under Regulation 74(5) of the SEBI (Depositories and Participants) Regulations, 2018 for the quarter ended 30" September, 2026 2. Regulation 57(5)- Non- Applicability Certificate Under Regulation 57(5) for the quarter ended 30 September, 2026 For Beryl Drugs Limited_ Sudhir Sethi Chairman& Di DIN: 00090172 BERHL DRUGS LIMITED TR ee lg .d :. (O 0f 7f 3. 1: )2 9 2, 1N 7e 6e 7r 7N a g Ear -, a" iM la :y a bn ek yW la dt re ur sP 2a 5rk yR ao ha od o" ., oBi mc h |o l Ci H Na p :s i L, 2I 4N 2D 3O MR PE 1- 94 95 32 P0 L1 C06 ( 7M 8. 4P. 0) INDIA Date: 06" October, 2026 The Compliance Department, BSE Ltd, Phiroze Jeejeebhoy Tower, 25" Floor, Dalal Street, Mumbai - 400001 BSE CODE: 524606 Sub: Compliance under regulation 57(5) for the quarter ended 30.09.2026. Dear Sir/Madam, We wish to inform that Regulation 57(5) is not applicable to our company since there is no non - convertible securities for which interest/dividend/principal is payable during the quarter ended 30.09.2026. You are requested to please take the same on record. For Beryl Drugs Limited DIN: 00090172